Research progress of cancer-related microRNAs

doi:10.3877/cma.j.issn.2095-8773.2015.03.002

Abstract

Abstract:

MicroRNAs (miRNAs) are a family of small non-coding RNAs with a length of 22 to 24 nucleotides, involved in post transcriptional regulation of gene expression through a complementary matching with the 3’ untranslated regions of target mRNAs, leading to either mRNA degradation or translational repression. miRNAs play an important role in all biological processes such as embryogenesis, cell proliferation, apoptosis and even in stem cell differentiation. Aberrant miRNAs expression is associated with many diseases including cancer. The key role which miRNAs play in cancer development and drug resistance has been investigated quickly since the first connection between cancer and miRNAs deregulation was discovered in the year of 2002. However, there is still a long way to fully understand the world of miRNAs. In this review, miRNAs biogenesis and role of miRNAs in cancer development and drug resistance are introduced, and how miRNAs can be used as biomarkers and as a novel therapeutic approach in cancer is described.

Key words: MicroRNA, Cancer, Biomarker

Yang Yang, Yifeng Sun, Wen Gao. Research progress of cancer-related microRNAs[J]. Chinese Journal of Thoracic Surgery(Electronic Edition), 2015, 02(03): 147-151.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhxbwkdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-8773.2015.03.002

https://zhxbwkdzzz.cma-cmc.com.cn/EN/Y2015/V02/I03/147

References 41

[1]	Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14[J]. Cell, 1993, 75(5): 843-854.
[2]	Reinhart BJ, Slack FJ, Basson M, et al. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans[J]. Nature, 2000, 403(6772): 901-906.
[3]	Lagos-Quintana M, Rauhut R, Lendeckel W, et al. Identification of novel genes coding for small expressed RNAs[J]. Science, 2001, 294(5543): 853-858.
[4]	Bartel DP. MicroRNAs: target recognition and regulatory functions[J]. Cell, 2009, 136(2): 215-233.
[5]	Calin GA, Dumitru CD, Shimizu M, et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia[J]. Proc Natl Acad Sci U S A, 2002, 99(24): 15524-15529.
[6]	Croce CM. Causes and consequences of microRNA dysregulation in cancer[J]. Nat Rev Genet, 2009, 10(10): 704-714.
[7]	Hwang HW, Mendell JT. MicroRNAs in cell proliferation, cell death, and tumorigenesis[J]. Br J Cancer, 2006, 94(6): 776-780.
[8]	Baranwal S, Alahari SK. miRNA control of tumor cell invasion and metastasis[J]. Int J Cancer, 2010, 126(6): 1283-1290.
[9]	Heinrich EM, Dimmeler S. MicroRNAs and stem cells control of pluripotency, reprogramming, and lineage commitment[J]. Circ Res, 2012, 110(7): 1014-1022.
[10]	Rosenfeld N, Aharonov R, Meiri E, et al. MicroRNAs accurately identify cancer tissue origin[J]. Nat Biotechnol, 2008, 26(4): 462-469.
[11]	Ma J, Dong C, Ji C. MicroRNA and drug resistance[J]. Cancer Gene Ther, 2010, 17(8): 523-531.
[12]	Martina Redova, Jiri Sana, Ondrej Slaby. Circulating miRNAs as new blood-based biomarkers for solid cancers[J]. Future Oncol, 2013, 9(3): 387-402.
[13]	Bader AG, Brown D, Stoudemire J, et al. Developing therapeutic microRNAs for cancer[J]. Gene Ther, 2011, 18(12): 1121-1126.
[14]	Lee Y, Kim M, Han J, et al. MicroRNA genes are transcribed by RNA polymerase Ⅱ[J]. EMBO J, 2004, 23(20): 4051-4060.
[15]	Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function[J]. Cell, 2004, 116(2): 281-297.
[16]	Sun Y, Chen C, Zhang P, et al. Reduced miR-3127-5p expression promotes NSCLC proliferation/invasion and contributes to dasatinib sensitivity via the c-Abl/Ras/ERK pathway[J]. Sci Rep, 2014, 4: 6527.
[17]	Calin GA, Sevignani C, Dumitru CD, et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers[J]. Proc Natl Acad Sci U S A, 2004, 101(9): 2999-3004.
[18]	Merritt WM, Lin YG, Han LY, et al. Dicer, Drosha, and outcomes in patients with ovarian cancer[J]. N Engl J Med, 2008, 359(25): 2641-2650.
[19]	Fabbri M, Calore F, Paone A, et al. Epigenetic regulation of miRNAs in cancer[J]. Adv Exp Med Biol, 2013, 754: 137-148.
[20]	Saito Y, Liang G, Egger G, et al. Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells[J]. Cancer Cell, 2006, 9(6): 435-443.
[21]	Fabbri M, Garzon R, Cimmino A, et al. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B[J]. Proc Natl Acad Sci U S A, 2007, 104(40): 15805-15810.
[22]	O'Donnell KA, Wentzel EA, Zeller KI, et al. c-Myc-regulated microRNAs modulate E2F1 expression[J]. Nature, 2005, 435(7043): 839-843.
[23]	Corney DC, Flesken-Nikitin A, Godwin AK, et al. MicroRNA-34b and microRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth[J]. Cancer Res, 2007, 67(18): 8433-8438.
[24]	Acunzo M, Romano G, Palmieri D, et al. Cross-talk between MET and EGFR in non-small cell lung cancer involves miR-27a and Sprouty2[J]. Proc Natl Acad Sci U S A, 2013, 110(21): 8573-8578.
[25]	Liang Z, Li Y, Huang K, et al. Regulation of miR-19 to breast cancer chemoresistance through targeting PTEN[J]. Pharm Res, 2011, 28(12): 3091-3100.
[26]	Shi GH, Ye DW, Yao XD, et al. Involvement of microRNA-21 in mediating chemo-resistance to docetaxel in androgen-independent prostate cancer PC3 cells[J]. Acta Pharmacol Sin, 2010, 31(7): 867-873.
[27]	Garofalo M, Di Leva G, Romano G, et al. miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 down regulation[J]. Cancer Cell, 2009, 16(6): 498-509.
[28]	Acunzo M, Visone R, Romano G, et al. miR-130a targets MET and induces TRAIL-sensitivity in NSCLC by downregulating miR-221 and 222[J]. Oncogene, 2012, 31(5): 634-642.
[29]	Bao L, Hazari S, Mehra S, et al. Increased expression of P-glycoprotein and doxorubicin chemoresistance of metastatic breast cancer is regulated by miR-298[J]. Am J Pathol, 2012, 180(6): 2490-2503.
[30]	Zhu H, Wu H, Liu X, et al. Role of microRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells[J]. Biochem Pharmacol, 2008, 76(5): 582-588.
[31]	Zhu X, Li H, Long L, et al. miR-126 enhances the sensitivity of non-small cell lung cancer cells to anticancer agents by targeting vascular endothelial growth factor A[J]. Acta Biochim Biophys Sin, 2012, 44(6): 519-526.
[32]	Romano G, Acunzo M, Garofalo M, et al. MiR-494 is regulated by ERK1/2 and modulates TRAIL induced apoptosis in non-small-cell lung cancer through BIM down-regulation[J]. Proc Natl Acad Sci U S A, 2012, 109(41): 16570-16575.
[33]	Volinia S, Calin GA, Liu CG, et al. A microRNA expression signature of human solid tumors defines cancer gene targets[J]. Proc Natl Acad Sci U S A, 2006, 103(7): 2257-2261.
[34]	Pencheva N, Tavazoie SF. Control of metastatic progression by microRNA regulatory networks[J]. Nat Cell Biol, 2013, 15(6): 546-554.
[35]	Png KJ, Halberg N, Yoshida M, et al. A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells[J]. Nature, 2011, 481(7380): 190-194.
[36]	Drusco A, Nuovo GJ, Zanesi N, et al. MicroRNA profiles discriminate among colon cancer metastasis[J]. PLoS One, 2014, 9(6): e96670.
[37]	Scholl V, Hassan R, Zalcberg IR. miRNA-451: a putative predictor marker of Imatinib therapy response in chronic myeloid leukemia[J]. Leuk Res, 2012, 36(1): 119-121.
[38]	Creemers EE, Tijsen AJ, Pinto YM. Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease？[J] Circ Res, 2012, 110(3): 483-495.
[39]	Chen X, Hu Z, Wang W, et al. Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel non-invasive biomarkers for non-small cell lung cancer diagnosis[J]. Int J Cancer, 2012, 130(7): 1620-1628.
[40]	Lagana A, Acunzo M, Romano G, et al. miR-Synth: a computational resource for the design of multi-site multi-target synthetic miRNAs[J]. Nucleic Acids Res, 2014, 42(9): 5416-5425.
[41]	Choi KY, Silvestre OF, Huang XL, et al. A nanoparticle formula for delivering siRNA or miRNAs to tumor cells in cell culture and in vivo[J]. Nat Protoc, 2014, 9(8): 1900-1915.

Please choose a citation manager

Content to export